GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Parabilis Medicines, Inc. Common Stock PBLS · USD

US listing · 🇺🇸 United States

Compare

30.37

+6.45%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Net income

−$145.9m

FY2024FY2025

Free cash flow

−$124.0m

FY2024FY2025

Shareholders' equity

−$16.5m

FY2024FY2025

Income statement

Fiscal years

FY2025FY2024
Research and development$125.6m$100.8m
Operating income−$152.1m−$126.1m
Net income−$145.9m−$117.9m
Diluted earnings per share-72.25-60.96

Balance sheet

At each fiscal year end

FY2025FY2024
Total assets$80.8m$149.3m
Cash and short-term investments$27.7m$88.0m
Total liabilities$97.3m$92.8m
Debt$20.9m$22.2m
Shareholders' equity−$16.5m$56.4m
Shares outstanding2m2m

Cash flow

Fiscal years

FY2025FY2024
Cash from operations−$123.7m−$103.6m
Capital spending−$306,000−$879,000
Free cash flow−$124.0m−$104.5m

Latest quarters

By quarter end

Jun 2026Mar 2026Jun 2025Mar 2025
Revenue$148,000———
Gross profit$148,000—−$618,000—
Operating income−$50.9m−$47.5m−$36.5m−$40.2m
Net income−$52.5m−$45.3m−$34.8m−$38.3m
Diluted earnings per share-1.81-1.57-17.24-18.98
Cash from operations−$3.0m−$49.0m−$31.0m−$34.0m
Total assets$1.18bn$384.2m——
Cash and short-term investments$1.12bn$329.0m——
Debt$14.0m$17.4m——
Shareholders' equity$1.05bn$244.2m——

Financial ratios

Data as of 19 Oct 2026

FY2025FY2024
Return on equity882.9%-208.9%
Return on assets-180.5%-79.0%
Free cash flow yield-268.7%—
Earnings growth23.7%—
Current ratio0.52x2.84x
Debt to equity-1.26x0.39x
Equity ratio-20.4%37.8%
Interest coverage-94.85x-78.35x

Market value over time

30 Jun 2026 to 16 Oct 2026, in USD

$3.23bn$657.7m

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.